The effects of neck manual therapy on the carpal tunnel syndrome

Not Applicable

Conditions: Carpal Tunnel Syndrome.
Carpal tunnel syndrome
G56.0

Registration Number: IRCT20201201049565N1

Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 40

Inclusion Criteria

Tingling, numbness, burning or pain in at least 2 of digits 1, 2 or 3
Ages 18-60 years
Positive Phalen sign or Tinnel sign over the carpal tunnel or carpal compression test
CTS symptoms present for greater than twelve weeks
Pain intensity at least a 4/10 on a Visual Analog Scale scale over the past 24 h
Electrodiagnostic findings indicate mild to moderate damage to the median nerve

Exclusion Criteria

Any sensory or motor deficit in either the ulnar or radial nerve
History of surgery or injection in the wrist area
Presence of systemic diseases such as rheumatoid arthritis, fibromyalgia
A history of systemic disease associated with carpal tunnel syndrome (such as diabetes mellitus or hyperthyroidism or hypothyroidism)
The presence of conditions that might cause numbness in the hand, including cervical radiculopathy, cervical ribs, plexopathy, and polyneuropathy
Pregnancy
History of neck, shoulder or upper extremity trauma

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: One day before first session of treatment, two or three days after end of treatment. Method of measurement: Visual Analog Scale.;Upper limb level of function. Timepoint: One day before first session of treatment, two or three days after end of treatment. Method of measurement: Disabilities of the arm, shoulder and hand (DASH) questionnaire.;Symptoms and functional status of patients. Timepoint: One day before first session of treatment, two or three days after end of treatment. Method of measurement: Boston Carpal Tunnel(BCTQ) Questionnaire.;Median sensory nerve conduction velocity. Timepoint: One day before first session of treatment, two or three days after end of treatment. Method of measurement: Tru trace 4 EMG system DEYMED electromyography device.;Median nerve motor distal latency. Timepoint: One day before first session of treatment, two or three days after end of treatment. Method of measurement: Tru trace 4 EMG system DEYMED electromyography device.

Secondary Outcome Measures